Kyoko Baba

Dr. Kyoko Baba

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Open access
KBKyoko Baba
Kyoko Baba
YYYasuharu Yamazaki
Yasuharu Yamazaki
YSYumiko Sone
Yumiko Sone
YSYoshika Sugimoto
Yoshika Sugimoto
KMKazuno Moriyama
Kazuno Moriyama
ATAkira Takeda
Akira Takeda
Umbilical cord blood-derived platelet-rich plasma (UCB-PRP) containing growth factors has attracted attention as a biomaterial useful for regenerative medicine. The osteoblastic differentiation of umbilical cord-derived mesenchymal stromal cells (UC-MSCs) can be induced by UCB-PRP. Nine samples of UC and UCB were used to conduct an in vitro study that determined the contents of three growth factors (i.e., platelet-derived growth factor, transforming growth factor β-1, and vascular endothelial growth factor) and that examined, by staining with Alizarin red, their ability to induce the osteoblastic differentiation of UC-MSCs at the baseline, 3 months, and 3 years of cryopreservation. The contents of growth factors in cryopreserved UCB-PRP were markedly elevated compared to those found in UCB at baseline. The samples of UCB that were added with cryopreserved UCB-PRP and those with bone morphogenetic protein-2 were stained granularly with Alizarin red, thus indicating the presence of calcium. The samples of UCB that were not added with UCB-PRP were not stained with Alizarin red. The above-mentioned contents and ability were maintained at 3 years of cryopreservation. Cryopreserved UCB-PRP possibly and advantageously induced the osteoblastic differentiation of UC-MSCs. The potential clinical application of cryopreserved UCB-PRP to regenerative medicine was suggested.

1 December 2012 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
KBKyoko Baba
Kyoko Baba
YYYasuharu Yamazaki
Yasuharu Yamazaki
SIShigehiro Ikemoto
Shigehiro Ikemoto
KAKazuya Aoyagi
Kazuya Aoyagi
ATAkira Takeda
Akira Takeda
EUEiju Uchinuma
Eiju Uchinuma

4 January 2022 in Medicina
Verified
Journal Article
Open access
PDF file
YNYuta Niimi
Yuta Niimi
KBKyoko Baba
Kyoko Baba
MTMasako Tsuchida
Masako Tsuchida
ATAkira Takeda
Akira Takeda
Background and Objectives: Wound healing (WH) is a complex natural process: the achieving of a proper WH with standard therapies sometimes is not fulfilled and it is often observed in aged and diabetic patients, leading to intractable ulcers. In recent years, autologous micrograft (AMG) therapies have become a new, effective, and affordable wound care strategy among both researchers and clinicians. In this study, a 72-year-old female patient underwent a combination of treatments using micrograft and negative pressure wound therapy (NPWT) on a postoperative skin ulcer after a benign tumor resection on the back with the aim to present an innovative method to treat skin ulceration using AMG combined with an artificial dermal scaffold and NPWT. Materials and Methods: A section of the artificial dermal scaffold, infused with micrografts, was sampled prior to transplant, and sections were collected postoperatively on days 3 and 7. Hematoxylin-eosin (HE) and immunohistochemical stains were employed for the evaluation of Cytokeratin AE1/AE3, desmin, and Factor VIII. Additionally, on postoperative day 3, NPWT dressing was evaluated using HE stains, as well. The resulting HE and immunostaining analysis revealed red blood cells and tissue fragments within the collagen layers of the artificial dermis prior to transplant. On postoperative day 3, collagen layers of the artificial dermis revealed red blood cells and neutrophils based on HE stains, and scattering of cytokeratin AE1/AE3-positive cells were detected by immunostaining. The HE stains on postoperative day 7 showed more red blood cells and neutrophils within the collagen layers of the artificial dermis than on day 3, an increase in cytokeratin AE1/AE3-positive cells, and tissue stained positively with desmin and Factor VIII. Results: Results suggest that the effects of both micrografts and migratory cells have likely accelerated the wound healing process. Furthermore, the NPWT dressing on day 3 showed almost no cells within the dressing. This indicated that restarting NPWT therapy immediately after micrograft transplant did not draw out cells within the scaffold. Conclusions: Micrograft treatment and NPWT may serve to be a useful combination therapy for complex processes of wound healing.

6 February 2025 in Cureus
Verified
Journal Article
Open access
YAYuki Ando
Yuki Ando
RIRisako Ito
Risako Ito
HMHiromi Matsuo
Hiromi Matsuo
KBKyoko Baba
Kyoko Baba
We report a rare case of a smooth muscle tumor of uncertain malignant potential arising in the inguinal soft tissue, requiring differential diagnosis from metastatic lymphadenopathy. The patient was a 74-year-old male.

1 January 2024 in Medical Research Archives
Verified
Journal Article
Open access
PDF file
KBKyoko Baba
Kyoko Baba
RIRisako Ito
Risako Ito
YAYuki Ando
Yuki Ando
AKAmi Kuwabara
Ami Kuwabara
YNYuta Nimi
Yuta Nimi
ATAkira Takeda
Akira Takeda
Introduction: Urachal remnant disease occurs when the fetal urachus fails to close after birth. We perform surgical excision of umbilical sinus-type urachal remnants, aiming for complete resection to prevent residual urachal epithelium, which may become a source for urachal carcinoma. This study reports immunohistochemical findings from surgical specimens to assess epithelial involvement and inform resection strategies. Materials and Methods: We reviewed cases of urachal remnant excision performed over one year at the Department of Plastic Surgery, Kitasato University Medical Center. Patient characteristics, including age, sex, symptoms, MRI findings, length of resected cord-like structures, and histopathological results, were examined. Histological evaluation included hematoxylin and eosin (H&E) staining and immunohistochemistry. Markers used were keratin AE1/AE3 and epithelial membrane antigen (EMA) for epithelial cells, factor VIII for vascular endothelium, α-smooth muscle actin (αSMA) for smooth muscle cells, and S-100 protein for nerve fibers. Results: Five patients (3 males, 2 females; age range 16–69 years) underwent surgery for urachal remnant disease. All presented with peri-umbilical inflammation. Preoperative MRI identified tubular structures ranging from 1.2 to 6.4 cm, while the resected cord-like structures measured 6 to 11 cm. The resected specimens were 3 to 5.2 cm longer than the tubular structures seen on MRI, and no tubular structures were observed at the surgical margins. Three cases showed clear tubular structures on H&E staining, all of which were positive for keratin AE1/AE3 and EMA, with keratin AE1/AE3 showing stronger staining. The remaining two cases, without clear tubular structures, were negative for keratin AE1/AE3 and EMA. αSMA was positive in all cases, while no significant findings were noted with factor VIII or S-100 protein. Discussion: The ideal resection range for urachal remnants remains unclear. In this study, resecting at least 2 cm beyond inflammatory signs during surgery, combined with intraoperative confirmation of the absence of tubular structures, resulted in complete excision. Immunohistochemical staining, particularly keratin AE1/AE3, was valuable in identifying residual epithelial components, while αSMA was useful for assessing remnant structures.

15 December 2024 in Cureus
Verified
Journal Article
Open access
KBKyoko Baba
Kyoko Baba
RIRisako Ito
Risako Ito
YAYuki Ando
Yuki Ando
HYHaruno Yoshida
Haruno Yoshida
TTTakashi Takahashi
Takashi Takahashi
Necrotizing soft tissue infections (NTSIs) represent a concept of necrotizing infections involving the skin, subcutaneous tissue, fascia, and muscle, and it is a potentially fatal disease. Early exploratory incision is strongly recommended for both the diagnosis and treatment of necrotizing soft tissue infections. Treatment of necrotizing soft tissue infections requires the administration of appropriate antimicrobial agents and adequate surgical debridement. The emergence of M1UK-lineage Streptococcus pyogenes (S. pyogenes) is recently reported in the UK, Canada, the USA, and the Netherlands. We report a Japanese case of sartorius muscle (SM) NTSI caused by M1UK-lineage S. pyogenes. A 34-year-old man developed redness and swelling of his right thigh anterior compartment with fever in October 2024. The closed and deep effusions by active exploratory incision/debridement on hospital days one to three yielded the presence of Gram-positive cocci, although two sets of blood cultures upon admission revealed no bacterial growth; its species identification results indicated S. pyogenes. Clinical and pathological diagnosis was streptococcal SM NTSI (without toxic shock syndrome (TSS)). Negative pressure wound therapy with instillation and dwelling (NPWTi-d) to promote his soft tissue cure was performed along with antimicrobial regimens. The patient recovered and received micrografting (carrier: artificial dermis made from collagen sponge and silicon film, Pelnac Gplus® (Gunze Limited, Osaka, Japan) using the Rigenera® system (Rignera HBW, Candiolo, Italy). Thereafter, he developed bronchitis: the sputum yielded S. pyogenes growth: he recovered uneventfully. Split-thickness skin grafting (STG) was performed. Split-thickness skin grafting was fully engrafted, and the wounds achieved complete healing. The patient could walk by himself. Microbiological genetic analyses using both DNAs from effusion/sputum-origin strains revealed the emm1.0 and speA-speB-smeZ profiles. rofA-gldA-pstB sequencing results indicated M1UK-specific single-nucleotide polymorphisms. The streptococcal inhibitor of the complement-mediated lysis gene allele was the streptococcal inhibitor of the complement-mediated lysis-1.02 allele. Micrografting using the Rigenera® system and STG following NPWTi-d can be beneficial approaches. Clinicians should perform cultures using sterile specimens (deep effusions/tissues) from infection foci through exploratory incision/debridement, along with two sets of blood cultures, when examining patients with/without underlying medical conditions.